Cite
HARVARD Citation
Engelholm, L. et al. (2016). Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180. Journal of pathology. 238 (1), pp. 120-133. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Engelholm, L. et al. (2016). Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180. Journal of pathology. 238 (1), pp. 120-133. [Online].